Submit Content
Get the latest delivered to your inbox
Privacy Policy

Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2012, the Group achieved net sales of USD 56.7 billion, while R&D throughout the Group amounted to approximately USD 9.3 billion (USD 9.1 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 129,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com.

 

Novartis is on Twitter. Sign up to follow @Novartis at twitter.com/novartis.

    Novartis Foundation Symposium Discusses Psychosocial Support To Help Vulnerable Children Achieve Mental Health And Wellbeing For A Better Future In Sub-Saharan Africa  Image

    POSTED 

    12-04-12

    Novartis Foundation Symposium Discusses Psychosocial Support To Help Vulnerable Children Achieve Mental Health And Wellbeing For A Better Future In Sub-Saharan Africa

     

    • Symposium speakers assess psychosocial approaches and discuss various interventions to ensure mental health and wellbeing for Africa's children
    • Experts present findings from REPSSI, the Regional Psychosocial Support Initiative ...
    Novartis International BioCamp Highlights Global R&D Reach to Meet Patient Needs in Emerging Markets  Image

    POSTED 

    08-29-12

    Novartis International BioCamp Highlights Global R&D Reach to Meet Patient Needs in Emerging Markets

    Novartis International BioCamp Highlights Global R&D Reach to Meet Patient Needs in Emerging Markets

    • International event brings 60 university students from 21 countries and territories to Novartis headquarters in Basel, Switzerland
    More Than 25,000 Novartis Associates Worldwide to Volunteer for Local Causes in Community Partnership Day Image

    POSTED 

    04-26-12

    More Than 25,000 Novartis Associates Worldwide to Volunteer for Local Causes in Community Partnership Day

    • Novartis associates worldwide to dedicate 200,000 work hours to supporting the local community 
    • Highest associate participation to date; activities now benefiting hundreds of charities in 54 countries
    • Annual volunteer event...
    Novartis Launches the Cancer Cell Line Encyclopedia (CCLE) to Catalogue World's Cancer Cell Lines Image

    POSTED 

    03-28-12

    Novartis Launches the Cancer Cell Line Encyclopedia (CCLE) to Catalogue World's Cancer Cell Lines

     

    • Collaboration with the Broad Institute yields comprehensive encyclopedia of genetic and molecular information for nearly 1,000 cancer cell lines
    • Encyclopedia, publicly available, may improve the design of cancer trials and advance cance...
    Delivery Of Child-Friendly Antimalarial Hits The 100 Million Mark Image

    POSTED 

    02-22-12

    Delivery Of Child-Friendly Antimalarial Hits The 100 Million Mark

    One hundred million treatments of Coartem®Dispersible (artemether-lumefantrine), an antimalarial developed especially for children with P. falciparum malaria, have been delivered by Novartis to 39 malaria-endemic countries, Medicines for Malaria Venture (MMV) announce...

    Novartis Extends Commitment to Help Achieve Final Elimination of Leprosy Image

    POSTED 

    01-30-12

    Novartis Extends Commitment to Help Achieve Final Elimination of Leprosy

    • New five-year commitment includes donation of treatments worth an estimated USD 22.5 million and is expected to reach an estimated 850,000 patients
    • Novartis will also intensify efforts to build a multi-stakeholder initiative in a final push against leprosy
    Novartis Foundation symposium looks at impact of Information and Communication Technology on democratization and development Image

    POSTED 

    12-02-11

    Novartis Foundation symposium looks at impact of Information and Communication Technology on democratization and development

    • Experts analyze how e-health applications improve access to quality healthcare and help contribute to achieving the health-related Millennium Development Goals
    • The symposium discusses the role of social media platforms in the Arab Spring and the impact of mobil...
    Novartis Associates Participate in First Company-Wide Health and Well-Being Initiative Image

    POSTED 

    09-19-11

    Novartis Associates Participate in First Company-Wide Health and Well-Being Initiative

    Novartis Group Company associates across 32 countries will participate in a new Novartis health and well-being initiative during the first Novartis Be Healthy Celebration Week from September 19-23, 2011. During the week, Novartis Group sites are offering many opportunities to help associates take...

    Novartis International BioCamp Spotlights How Diversity Spurs Innovation Across The Company And Inspires Future Science Leaders Image

    POSTED 

    08-29-11

    Novartis International BioCamp Spotlights How Diversity Spurs Innovation Across The Company And Inspires Future Science Leaders

    • The interactive BioCamp program engages students around scientific advances and entrepreneurial opportunities
    • The eighth annual event brings 60 top university students from 24 countries and territories to Novartis headquarters in Basel, Switzerland 
    • Novartis is an inclusive...
    Representatives of the UN, NGOs and private sector discuss new approaches to achieving the Millennium Development Goals at the Novartis Foundation symposium Image

    POSTED 

    12-03-10

    Representatives of the UN, NGOs and private sector discuss new approaches to achieving the Millennium Development Goals at the Novartis Foundation symposium

    • Experts from North and South continue the New York Millennium Summit dialogue at the annual symposium held by the Novartis Foundation for Sustainable Development in Basel

    • The symposium will assess the progress made to date in achieving...
    Novartis Logo

    Novartis

    Novartis

    Join today and get the latest delivered to your inbox